N511 Module 4 assignment: Shadow Health focused exam reflection essay on community-acquired pneumonia prescribing, a full sample

Two Antibiotics That Spare the QT Interval: Reflecting on Outpatient Treatment of Community-Acquired Pneumonia in a 64-Year-Old With Diabetes Taking Citalopram

Student Name

Master of Science in Nursing Program, Aspen University

N511: Advanced Pharmacology

Instructor Name

Month Day, Year

Two Antibiotics That Spare the QT Interval: Reflecting on Outpatient Treatment of Community-Acquired Pneumonia in a 64-Year-Old With Diabetes Taking Citalopram

Community-acquired pneumonia is often treated with a short list of familiar regimens, and the simplest, a macrolide or a respiratory fluoroquinolone, can seem automatic. In this module's ShadowHealth exam I met a digital patient for whom both of those choices carried a risk I nearly overlooked. This essay reflects on how I assessed him and then answers the module's prompts on prescribing, alternatives, monitoring, adverse effects, interactions, education, and prevention.

The Case and My Performance

This composite patient is a 64-year-old retired bus mechanic with four days of productive cough, fever to 38.6 °C, and right-sided pleuritic chest pain. He has type 2 diabetes treated with metformin and takes citalopram 40 mg daily for depression. His respiratory rate is 22, his pulse oximetry reads 94 percent without supplemental oxygen, blood pressure 128/78 mm Hg, and he is alert. The chest radiograph shows right lower lobe consolidation. His glucose at the visit was 212 mg/dL. He has not taken antibiotics in the past three months and has no history of resistant organisms.

My assessment was strong on the respiratory examination and severity assessment. I used the Pneumonia Severity Index, which the guideline prefers for deciding the site of care (Metlay et al., 2019); his age and findings placed him in a low-risk class suitable for outpatient treatment with close follow-up. My weakness was that I selected an antibiotic before reviewing his medication list and recognized the citalopram interaction only in the debrief.

The Regimen I Would Prescribe and Why

Because he has diabetes, a comorbidity the guideline uses to identify outpatients at higher risk of resistant or more virulent organisms, he needs broader coverage than a healthy adult. The ATS/IDSA guideline offers two approaches for such patients: a beta-lactam, such as amoxicillin-clavulanate, combined with a macrolide or doxycycline, or monotherapy with a respiratory fluoroquinolone (Metlay et al., 2019).

I would prescribe amoxicillin-clavulanate 875/125 mg twice daily plus doxycycline 100 mg twice daily, for a minimum of five days and until he is clinically stable. Amoxicillin-clavulanate covers Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae, and doxycycline covers atypical organisms such as Mycoplasma and Legionella.

Citalopram is the reason I avoided both of the other options. Citalopram prolongs the QT interval in a dose-dependent way, and 40 mg is the maximum recommended dose. Azithromycin and levofloxacin also prolong the QT interval, and combining QT-prolonging drugs increases the risk of torsades de pointes. A large cohort study found that a five-day course of azithromycin was associated with a small increase in cardiovascular death, concentrated among patients with a high baseline cardiovascular risk (Ray et al., 2012). Fluoroquinolones carry further concerns for him, including dysglycemia in patients with diabetes. Doxycycline gives him atypical coverage without adding to a QT interval his antidepressant has already lengthened.

How the Two Drugs Work

Amoxicillin binds penicillin-binding proteins in the bacterial cell wall and prevents the cross-linking of peptidoglycan, so dividing bacteria lyse. Many strains of Haemophilus influenzae and Moraxella catarrhalis produce beta-lactamase enzymes that destroy amoxicillin, and clavulanate binds and inactivates those enzymes, restoring amoxicillin's activity. Its killing depends on how long drug levels stay above the organism's inhibitory concentration, which is why regular twice-daily dosing matters more than a large single dose.

Doxycycline binds the 30S ribosomal subunit and blocks protein synthesis, stopping bacterial growth. Because Mycoplasma has no cell wall and Legionella and Chlamydophila live inside host cells, beta-lactams cannot reach them, while doxycycline penetrates cells well. Doxycycline is well absorbed orally, is eliminated partly through the bile, and needs no dose change for reduced kidney function, which suits an older adult whose kidney function may shift during an acute illness.

Second-Line Options

If he could not take amoxicillin-clavulanate, for example because of a penicillin allergy that testing did not clarify, a second- or third-generation cephalosporin such as cefpodoxime could replace it, still combined with doxycycline (Metlay et al., 2019). If a fluoroquinolone became necessary, I would first obtain an electrocardiogram, check potassium and magnesium, and discuss temporarily lowering the citalopram dose with the prescriber, rather than simply adding the drug.

Monitoring and Adverse Reactions

I would arrange a telephone check at 48 hours and a visit at 72 hours to confirm improvement in fever, breathing, and appetite. Worsening shortness of breath, confusion, or oxygen saturation below 92 percent would require reassessment for admission. Because acute infection raises blood glucose, he should check his glucose more often during the illness. A repeat chest radiograph is not needed routinely if he recovers.

Amoxicillin-clavulanate commonly causes diarrhea, and the clavulanate component contributes to it; any severe or bloody diarrhea should be reported because of the risk of Clostridioides difficile infection. Doxycycline can cause esophageal ulceration and photosensitivity.

Interactions and Education

Doxycycline binds calcium, magnesium, aluminum, and iron, so antacids, dairy, and iron supplements should be separated from doses by at least two hours. Metformin should be held if he becomes dehydrated from vomiting or poor intake, since dehydration and acute illness increase the risk of lactic acidosis.

He should take doxycycline with a full glass of water and remain upright for at least 30 minutes, take amoxicillin-clavulanate with food to reduce stomach upset, use sunscreen, complete the course, and rest while staying hydrated. I would also explain the warning signs that should prompt a same-day call.

Prevention and Lifestyle

After recovery, prevention matters as much as treatment. Current immunization guidance recommends pneumococcal conjugate vaccination for adults younger than 65 who have diabetes, using either the 20-valent vaccine alone or the 15-valent vaccine followed by the 23-valent polysaccharide vaccine (Kobayashi et al., 2022), so he should be offered it once he recovers, along with an annual influenza vaccine. Improving glucose control and avoiding smoking reduce his risk of future respiratory infections. The follow-up visit is also a chance to review whether his citalopram dose is still necessary, since that decision affects future antibiotic choices.

Carrying the Lesson Forward

The exam taught me to review the medication list before selecting any antimicrobial. The guideline narrowed my options, but his antidepressant made the decision. In future exams I will check each antibiotic for QT effects and interactions against the patient's full medication list, and I will document why the usual regimen was changed so the next clinician understands the choice.

References

Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., Poehling, K. A., & Pilishvili, T. (2022). Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: Updated recommendations of the Advisory Committee on Immunization Practices, United States, 2022. MMWR. Morbidity and Mortality Weekly Report, 71(4), 109-117. https://doi.org/10.15585/mmwr.mm7104a1

Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45-e67. https://doi.org/10.1164/rccm.201908-1581ST

Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012). Azithromycin and the risk of cardiovascular death. New England Journal of Medicine, 366(20), 1881-1890. https://doi.org/10.1056/NEJMoa1003833